Post‐diagnostic metformin and statin use and risk of biochemical recurrence in Veterans diagnosed with prostate cancer
Abstract
To evaluate the impact of post‐diagnostic metformin or statin use and duration on risk of biochemical recurrence in a racially‐diverse cohort of Veterans.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- May 16, 2023
- Source ID
- 10.1002/pros.24557
Entities
People
- Amanda A. Seyerle
- Bettina F. Drake
- Mei Wang
- Saira Khan
- Su‐hsin Chang
- Veronica Hicks
Organizations
- Alvin J. Siteman Cancer Center
- Foundation for Barnes-Jewish Hospital
- UNC Eshelman School of Pharmacy
- United States Department of Defense
- University of Delaware
- Veterans Health Administration
- Washington University in St. Louis